» Authors » Delfin Rodriguez-Leyva

Delfin Rodriguez-Leyva

Explore the profile of Delfin Rodriguez-Leyva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Leyva D, Pierce G
Nutrients . 2021 Jun; 13(6). PMID: 34064053
The coronavirus disease 2019 (COVID-19) pandemic has had significant morbidity, mortality, social and financial implications for the global population. Despite this knowledge, we still know very little about how COVID-19...
2.
Skulas-Ray A, Wilson P, Harris W, Brinton E, Kris-Etherton P, Richter C, et al.
Circulation . 2019 Aug; 140(12):e673-e691. PMID: 31422671
Hypertriglyceridemia (triglycerides 200-499 mg/dL) is relatively common in the United States, whereas more severe triglyceride elevations (very high triglycerides, ≥500 mg/dL) are far less frequently observed. Both are becoming increasingly...
3.
Rodriguez-Portelles A, Rodriguez-Leyva D
Can J Physiol Pharmacol . 2019 Jul; 97(10):1006-1011. PMID: 31269406
Smoking is associated with endothelial and left ventricular diastolic disfunction. We aimed to determine the endothelial and diastolic function in young adults exposed to tobacco smoke and the effects of...
4.
Rodriguez-Leyva D, Rodriguez-Portelles A, Weighell W, Guzman R, Maddaford T, Pierce G
Can J Physiol Pharmacol . 2018 Oct; 97(6):557-561. PMID: 30308127
Patients with peripheral artery disease (PAD) are at increased risk for cardiovascular events, and higher susceptibility for cardiac arrhythmias may be involved. The objectives of this double-blinded randomized controlled FLAX-PAD...
5.
Morales Salinas A, Coca A, Olsen M, Sanchez R, Sebba-Barroso W, Kones R, et al.
Curr Probl Cardiol . 2017 May; 42(7):198-225. PMID: 28552207
Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99mmHg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular...
6.
Caligiuri S, Rodriguez-Leyva D, Aukema H, Ravandi A, Weighell W, Guzman R, et al.
Hypertension . 2016 Aug; 68(4):1031-8. PMID: 27528063
Unlabelled: In the year-long FlaxPAD clinical trial (Flaxseed for Peripheral Artery Disease), dietary flaxseed generated a powerful reduction in brachial systolic and diastolic blood pressure in patients with peripheral artery...
7.
Pierce G, Rodriguez-Leyva D, Caligiuri S, Edel A
J Nutr . 2015 Nov; 145(11):2630-1. PMID: 26525907
No abstract available.
8.
Edel A, Rodriguez-Leyva D, Maddaford T, Caligiuri S, Austria J, Weighell W, et al.
J Nutr . 2015 Feb; 145(4):749-57. PMID: 25694068
Background: Dietary flaxseed lowers cholesterol in healthy subjects with mild biomarkers of cardiovascular disease (CVD). Objective: The aim was to investigate the effects of dietary flaxseed on plasma cholesterol in...
9.
Holub B, Mutch D, Pierce G, Rodriguez-Leyva D, Aliani M, Innis S, et al.
Appl Physiol Nutr Metab . 2014 Apr; 39(7):754-62. PMID: 24749841
The science of lipid research continues to rapidly evolve and change. New knowledge enhances our understanding and perspectives on the role of lipids in health and nutrition. However, new knowledge...
10.
Rodriguez-Leyva D, Weighell W, Edel A, Lavallee R, Dibrov E, Pinneker R, et al.
Hypertension . 2013 Oct; 62(6):1081-9. PMID: 24126178
Flaxseed contains ω-3 fatty acids, lignans, and fiber that together may provide benefits to patients with cardiovascular disease. Animal work identified that patients with peripheral artery disease may particularly benefit...